Low-molecular-weight herapin, bemiparin, in the outpatient treatment and secondary prohylaxis of venous thromboembolism in standard clinical practice: The ESFERA study

International Journal of Clinical Practice

Volumn 60, Issue 5, 2006, Pages 518-525

  Santamaría, Amparo ^a,e   Juarez S ^b,e   Reche, A ^c,e   Gomez Outes A ^d   Martinez Gonzalez J ^d   Fontcuberta, J ^a,e   Puig, A ^e   Mairal, A ^e   Albiol, J M ^e   Espinosa, G ^e   Paniagua, J ^e   Fernandez A ^e   Felix Nunez G ^e   Gutierrez J ^e   Friego, F ^e   de la Pena C ^e   Lopez F ^e   Gresser, J V ^e   Llorens, P ^e   Tordera, P ^e   Bonanad, S ^e   Velasco, S ^e   Arzuaga, J A ^e   Ayensa, J ^e   Arnelles, A ^e   Rodriguez S J ^e   Morales, J ^e   Munoz J A ^e   Ruiz, D ^e   Munoz M ^e   Bonilla, F ^e   Arribas, J M ^e   Glenn, V ^e   Barba, A ^e   Sabio, F ^e   Alonso, M J ^e   Carrascos, F J ^e   Bravo, M ^e   Martin D ^e   Ortega, J M ^e   Alberto, J L ^e   Valdes P ^e   Salazar, A ^f   Martin A ^e   Marinelo, J ^e   Abadia F ^e   Pacho, J ^e   Cabot, J ^e   Zapico, N ^e   Ascensino, A ^e   Arevalo A ^e   Leon F ^e   Janer, J ^e   Mosquera, N J ^e   Rodriguez G ^e   Oriamas, M ^e   Gutierrez J M ^e   Valle, R ^e   Reales, P ^e   Zaragoza, J M ^e   Roman P ^e   Garcia Fuster M J ^e   Noriega, D ^e   Carpintero, L A ^e   de la Cruz, J ^e   Garcia Ledesma F J ^e   more..

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^d Laboratorios Fcos ROVI SA   (Spain)

^e L'Hospitalet de Llobregat ^*

^f Cancer Epidemiology Research Program   (Spain)

Author keywords

Bemiparin; Long term treatment; Low molecular weight heparin; Oral anticoagulants; Outpatient treatment; Secondary prophylaxis; Venous thromboembolism

Indexed keywords

ACENOCOUMAROL; ANTITHROMBOCYTIC AGENT; BADYKET; BEMIPARIN; IVOR; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN K GROUP; WARFARIN; ZIBOR;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG COST; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTPATIENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 33646229797     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2006.00947.x     Document Type: Article

References (25)

1. Buller HR, Agnelli G, Hull RD et al. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic therapy. Chest 2004; 126 (Suppl.): 401S-28S.
2. Turpie AG, Chin BS, Lip GY. ABC of antithrombotic therapy: Venous thromboembolism: Treatment strategies. BMJ 2002; 325: 948-50.
3. Bergqvist D. Low molecular weight heparins. J Intern Med 1996; 240: 63-72.
4. Schraibman IG, Milne AA, Royle EM. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev 2001; 2: CD003076.
5. Smith BJ, Weekley JS, Pilotto L et al. Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to in patient treatment with unfractionated heparin. Intern Med J 2002; 32: 29-34.
6. Wells PS, Kovacs MJ, Bormanis J et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with homecare injection. Arch Intern Med 1998; 158: 1809-12.
7. Planes A. Review of bemiparin sodium - a new second - generation low molecular weight heparin -and its applications in venous thromboembolism. Expert Opin Pharmacother 2003; 4: 1551-61.
8. Kakkar VV, Gebska M, Kadziola Z et al. Bemiparin Investigators. Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis. Thromb Haemost 2003; 89: 674-80.
9. Gómez-Outes A, Rocha E, Martínez-González J et al. Cost effectiveness of bemiparin versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis. Pharmacoeconomics 2006; 24: 81-92.
10. Tillman DJ, Charland SL, Witt DM. Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization. Arch Intern Med 2000; 160: 2926-32.
11. Harrison L, McGinnis J, Crowther M et al. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998; 158: 2001-3.
12. ASHP therapeutic position statement on the use of low-molecular-weight heparins for adult outpatient treatment of acute deep-vein thrombosis. Am J Health Syst Pharm 2004; 61: 1950-5.
13. Order of 26th December 2001 of the General Section of the National Healthcare Institute. BOE 2002; 5: 637-9 [in Spanish]. http://www.boe.es (accessed on October 3 2005).
14. Foral Order 83/2002 of 15th May. Boletín Oficial de Navarra 2002; 91: 6530-41 [in Spanish]. http://www.cfnavarra.es (accessed on October 3 2005).
15. General Council of Official Associations of Pharmacists. Catalogue of Pharmaceutical Products. Madrid: General Council of Official Associations of Pharmacists, 2004.
16. González-Revaldería J, Pascual T, Sánchez ME et al. Cost analysis in the routine laboratory. VI Meeting of the Spanish Association for the Direction and Management of Clinical Laboratories, 2002 [in Spanish]. http://www.sediglac.org (accessed on October 3 2005).
17. Handbook of diagnostic procedures. Sevilla: Servicio Andaluz de Salud; 2000 [in Spanish]. http://www.juntadeandalucia.es (accessed on October 3 2005).
18. Ong BS, Karr MA, Chan DK et al. Management of pulmonary embolism in the home. Med J Aust 2005; 183: 239-42.
19. Kovacs MJ, Anderson D, Morrow B et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83: 209-11.
20. Siragusa S, Arcara C, Malato A et al. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol 2005; 16 (Suppl. 4): 136-9.
21. Aujesky D, Obrosky DS, Stone RA et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med 2006; 166: 169-75.
22. Matsagas MI. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview. Int Angiol 2004; 23: 305-16.
23. van der Heijden JF, Hutten BA, Buller HR et al. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev 2002; 1: CD002001.
24. Daskalopoulos ME, Daskalopoulou SS, Liapis CD. Low molecular weight heparins: The optimal treatment for venous thromboembolism. Curr Med Res Opin 2004; 20: 1001-5.
25. Iorio A, Guercini F, Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 2003; 1: 1906-13.